Marsh & McLennan Companies Inc.
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are trading lower after a DCF analysis indi...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk manag...
Latest News
6 days ago · gurufocus.com
MRSH DCF Analysis: Intrinsic Value $189 vs Price $195On October 27, 2026, we delve into the DCF analysis for Marsh (MRSH), a company that has shown a price performance of +3.3% over the past week and +14.5% over t
7 days ago · zacks.com
Can Marsh's Expanded Thrive Program Drive Margin Growth?Marsh raises Thrive's annual savings target 50% to $600 million, but higher restructuring costs and reinvestment could limit the boost to operating margins.
11 days ago · gurufocus.com
Marsh (MRSH) Stock Up 4.6% and Still Undervalued -- GF Score: 82/100On October 22, 2026, Marsh (MRSH) shares rose 4.6% to a current price of $199.27, edging closer to its 52-week high of $198.49. The stock has demonstrated posit
13 days ago · gurufocus.com
Marsh Stocks Rise 5.40% With JPMorgan's $218 Target in FocusRisk-and-insurance adviser Marsh (MRSH) needed another 9.7% gain to reach JPMorgan's $218 price target after trading at $198.67, up 5.40%, at 8:38 a.m. ET on Oc
14 days ago · fool.com
Marsh & McLennan: 3 Key Takeaways for Long-Term InvestorsManagement raised its Thrive program savings target to $600 million. London wholesale digital trading reached 93% using new workbench tools.
17 days ago · seekingalpha.com
Marsh & McLennan: Challenging Operating Environment Likely To Persist AheadMarsh & McLennan faces cyclical headwinds and margin pressure, prompting a downgrade to 'Hold' despite solid execution and strategic initiatives. Q3 2026 saw MRSH beat revenue and EPS estimates, but underlying growth slowed as P&C pricing trends and reinsurance weakness weighed on results. Cost-cutting targets were raised to $600 million by 2028, but inflation and wage pressures continue to erode operating margins, now at 17.7%.
18 days ago · zacks.com
Marsh Q3 Earnings Beat Estimates on Consulting Growth Despite Higher CostsMarsh's Q3 2026 earnings beat estimates as strong growth in Consulting and Risk and Insurance Services lifted revenues, despite rising operating expenses.
18 days ago · seekingalpha.com
Marsh & McLennan Companies, Inc. (MRSH) Q3 2026 Earnings Call TranscriptMarsh & McLennan Companies, Inc. (MRSH) Q3 2026 Earnings Call Transcript
18 days ago · marketbeat.com
Marsh & McLennan Companies Q3 Earnings Call HighlightsMarsh & McLennan Companies NYSE: MRSH reported third-quarter revenue growth and double-digit adjusted earnings-per-share growth, while increasing the savings target for its Thrive efficiency program and outlining additional investments in artificial intelligence, sales capacity and client services.
18 days ago · zacks.com
Marsh (MRSH) Q3 Earnings and Revenues Beat EstimatesMarsh (MRSH) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.96 per share. This compares to earnings of $1.85 per share a year ago.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove MRSH